Home » Newsletters » BioWorld

BioWorld

March 22, 1994

View Archived Issues

CORRECTION AND CLARIFICATION

TECHNOLOGY TRANSFER OPPORTUNITIES INSTITUTE OF STANDARDS OFFERS

HUMANIZED ANTIBODY TARGETS CANCER MARKER

GENELABS GAINS ACCESS TO CHINA VIA COLLABORATION

FDA QUESTIONS DELAY TESTING OF HEPARIN-LIKE DRUG

ADVANCES IN DRUGS TO TREAT C. PARVUM

ETHICS OF HUMAN RESEARCH REVIEWED

KNOCKING MICE OFF BALANCE ADVANCES NERVE-REGENERATION